Martin McCarter

After leaving MSKCC, I took a position at the University of Colorado Cancer Center with the University of Colorado Denver. Since then, I have been promoted to Associate Professor of Surgery and have witnessed the tremendous growth of the cancer center with the transition of the entire medical center to a new bioscience community at…

Read More

Martin Weiser

Following his KAC Surgical Oncology Fellowship, Martin Weiser gained additional training in minimally invasive colorectal surgery before joining the staff at MSKCC in 2001. His practice involves surgical treatment of primary, metastatic, and recurrent cancers of the colon, rectum, anus, and appendix, with a focus on preservation of sphincter function and maintenance of bladder and…

Read More

David Linehan

Dr. David C. Linehan is the Seymour Schwartz Distinguished Professor of Surgery and Oncology and Department of Surgery Chair at the University of Rochester Medical Center (URMC). He holds an additional appointment as the Associate Director of Clinical Research at Wilmot Cancer Institute. As the Founder and Director of the Center for Tumor Immunology Research,…

Read More

Kevin Billingsley

Following the completion of my fellowship in 1998 I moved to Seattle, Washington, where I joined the faculty at the University of Washington. My practice was as the Seattle Veterans Affairs Medical Center. During this time I focused my practice on gastrointestinal surgical oncology and sarcoma. I developed a regional multidisciplinary cancer program for the…

Read More

Lawrence Harrison

Lawrence E. Harrison is an Associate Professor of Surgery in the Department of Surgery and Chief of the Division of Surgical Oncology. He earned a B.A. degree in Chemistry at Franklin & Marshall College and his M.D. degree at Temple University Medical School. He completed his general surgical training at University of Massachusetts Medical Center.…

Read More

Martin Heslin

I left MSKCC in 1996 and moved with my family to Alabama to work at the University of Alabama at Birmingham in Surgical Oncology. The KACF fellowship helped me become a local expert in the management of soft tissue tumors of all sites. Our group at UAB has published articles on the role of preoperative…

Read More

Jon Lewis

I am currently the CEO of ZIOPHARM Oncology, a cancer drug development biotech company based out of New York and Boston. One of the lead drugs we are developing (Zymafos / Palifosfamide) is being developed in soft tissue sarcoma. This is a small molecule that works in a similar way to ifosfamide, with hopefully better…

Read More